Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer. Yoshikawa K, Ishida M, Yanai H, Tsuta K, et al. PLoS One 2021;16:e0257860.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yoshikawa K, Ishida M, Yanai H, Tsuta K, et al. Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer. PLoS One 2021;16:e0257860.
PMID: 34559865